| 000 | 01566 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513115221.0 | ||
| 264 | 0 | _c19970616 | |
| 008 | 199706s 0 0 eng d | ||
| 022 | _a0014-2999 | ||
| 024 | 7 |
_a10.1016/s0014-2999(97)00040-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHauber, W | |
| 245 | 0 | 0 |
_aMotor depressant effects mediated by dopamine D2 and adenosine A2A receptors in the nucleus accumbens and the caudate-putamen. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cApr 1997 |
||
| 300 |
_a127-31 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenosine _xanalogs & derivatives |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCatalepsy _xphysiopathology |
| 650 | 0 | 4 |
_aCaudate Nucleus _xdrug effects |
| 650 | 0 | 4 | _aDopamine D2 Receptor Antagonists |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMicroinjections |
| 650 | 0 | 4 |
_aMotor Activity _xdrug effects |
| 650 | 0 | 4 |
_aNeostriatum _xdrug effects |
| 650 | 0 | 4 |
_aNucleus Accumbens _xdrug effects |
| 650 | 0 | 4 |
_aPhenethylamines _xpharmacology |
| 650 | 0 | 4 | _aPurinergic P1 Receptor Agonists |
| 650 | 0 | 4 |
_aPutamen _xdrug effects |
| 650 | 0 | 4 | _aRaclopride |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aReceptor, Adenosine A2A |
| 650 | 0 | 4 |
_aSalicylamides _xpharmacology |
| 700 | 1 | _aMünkle, M | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 323 _gno. 2-3 _gp. 127-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0014-2999(97)00040-x _zAvailable from publisher's website |
| 999 |
_c9110349 _d9110349 |
||